| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | NEXGEL GAAP EPS of -$2.28 beats by $1.72, revenue of $3.18M misses by $2.08M | 4 | Seeking Alpha | ||
| Mi | NexGel beruft Aviv Argaman in den Verwaltungsrat und bildet Sonderausschuss zur Fusionsprüfung | 2 | Investing.com Deutsch | ||
| 12.11. | NEXGEL, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| NEXGEL Aktie jetzt für 0€ handeln | |||||
| 11.11. | NexGel secures 95% noteholder support for debt conversion | - | Investing.com | ||
| 11.11. | NEXGEL, INC.: NEXGEL Announces Noteholder Participation in Strategic Recapitalization and Approximately $1.2 Million in New Capital Funding | 2 | GlobeNewswire (USA) | ||
| 27.10. | Nexgel regains Nasdaq minimum bid price compliance | 1 | Investing.com | ||
| 27.10. | NEXGEL regains compliance with Nasdaq | 1 | Seeking Alpha | ||
| 27.10. | NEXGEL, INC.: NEXGEL Regains Compliance with Nasdaq Listing Requirement | 1 | GlobeNewswire (USA) | ||
| 12.10. | NEXGEL, INC.: NEXGEL Announces 1-for-20 Reverse Stock Split Effectiveness | 3 | GlobeNewswire (USA) | ||
| 07.10. | NEXGEL, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.09. | NexGel: Aktionäre genehmigen Kapitalerhöhung und Reverse Stock Split | 1 | Investing.com Deutsch | ||
| 23.09. | NEXGEL, INC. - 8-K, Current Report | 18 | SEC Filings | ||
| 23.09. | NEXGEL, INC.: NEXGEL Announces Dial-In Details for Investor Update Call | 2 | GlobeNewswire (USA) | ||
| 16.09. | NEXGEL, INC.: NEXGEL Announces Date for Investor Update Call | 1 | GlobeNewswire (USA) | ||
| 20.08. | NEXGEL appoints Brian Kieser as interim CEO after Adam Levy steps down | 1 | Seeking Alpha | ||
| 20.08. | NEXGEL, INC. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 19.08. | NEXGEL Recalls SilverSeal From Amazon To Launch Product Into Higher-Margin Hospital Market | 5 | pulse2.com | ||
| 17.08. | NEXGEL reports Q2 results | 2 | Seeking Alpha | ||
| 17.08. | NEXGEL, INC. - 8-K, Current Report | 6 | SEC Filings | ||
| 29.07. | NEXGEL, INC. - 8-K, Current Report | 4 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 6,986 | -1,77 % | Truist raises Teladoc stock price target to $9 on EBITDA outlook | ||
| SERNOVA BIOTHERAPEUTICS | 0,059 | 0,00 % | Sernova Biotherapeutics: 11,2 Millionen Dollar für die Fusion - und doch rutscht die Aktie | ||
| CERENOME | 0,541 | -7,52 % | Cerenome outlines $10M-$12.5M 2026 gross billings run rate exit while targeting mid-2027 REYOBIQ top line data | ||
| ATOSSA THERAPEUTICS | 1,570 | -2,48 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Nov. 10, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Rekord bei Umsatz und Gewinn - lächerliche Bewertung! | Sonoma Pharmaceuticals macht den nächsten gewaltigen Schritt auf dem Weg zum profitablen Wachstumsunternehmen. Nach dem erstmaligen Erreichen eines positiven EBITDA im Vorquartal meldet der Healthcare-Spezialist... ► Artikel lesen | |
| TANDEM DIABETES | 16,100 | +4,55 % | Warum die Aktie von Tandem Diabetes Care heute kräftig zulegt | ||
| CO-DIAGNOSTICS | 0,130 | -20,84 % | Co-Diagnostics Announces Reverse Stock Split | SALT LAKE CITY, Nov. 19, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Diagnostics" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| QUIDELORTHO | 7,790 | -4,09 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,145 | +1,66 % | Veru presents data on enobosarm for obesity treatment | ||
| LIFEWARD | 2,960 | +1,02 % | Lifeward GAAP EPS of -$1.32 misses by $0.50, revenue of $5.43M misses by $1.81M | ||
| CLOVER HEALTH INVESTMENTS | 3,470 | +1,17 % | CLOVER HEALTH INVESTMENTS, CORP. /DE - 8-K, Current Report | ||
| SENSEONICS | 8,800 | +8,64 % | Beta Bionics, Inc.: Senseonics and Beta Bionics Launch Eversense 365 and iLet Bionic Pancreas Integration | ||
| TEMPEST THERAPEUTICS | 0,295 | -3,69 % | Tempest Therapeutics: Tempest Reports Third Quarter 2026 Financial Results and Provides Business Update | ||
| NANO-X IMAGING | 0,230 | -0,04 % | NANO-X IMAGING LTD: Nanox to Showcase Its Innovative Technology and Advances Across Nanox.ARC X and Nanox.AI at RSNA 2026 | ||
| IMUNON | 0,416 | +4,00 % | Imunon, Inc.: IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer | Enrollment momentum exceeding expectations is based on highly promising survival (OS) data and well tolerated safety profile demonstrated in the Company's large, randomized Phase II study, OVATION... ► Artikel lesen |